Biden Health Care Enforcement Priorities

Biden Health Care Enforcement Priorities

Client Alert

Related Solutions

We help companies protect data, comply with evolving regulations, and respond to investigations and litigation.
Drawing on our extensive experience in senior government roles and in private practice, our team has successfully represented clients in difficult, high-stakes FCA investigations and litigation, and advised clients on practical strategies for reducing FCA risk through internal compliance programs.
Named an “FCPA Powerhouse” and “Practice Group of the Year,” we have been involved in some of the most notable public and non-public cases and key developments related to FCPA and anti-corruption issues.
Drawing on years of experience in the public and private sectors, our lawyers handle a range of litigation involving the federal government, state and foreign governments, and complex regulatory regimes.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Guiding clients through high-stakes and sensitive investigations.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A global team handling highly complex and sensitive matters in all aspects of litigation.
Critical industry insight and formidable strength across key practices.

The Biden Administration is expected to devote significant resources to investigating fraud and abuse in the health care industry. Not only will the Biden Administration likely continue investigating traditional health care priorities, but it likely will exercise heightened scrutiny over the use of funds relating to the COVID-19 pandemic and other current issues, such as nursing home care and the opioid epidemic. We also anticipate additional resources devoted to these investigations overall. In this alert, we outline each of the Biden Administration’s most likely enforcement priorities in this industry.

Read the full alert here. 

Authors

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel